Overview -
As demand for GLP-1 drugs continues to skyrocket, federal and state agencies are turning their attention to the GLP-1 market and ramping up efforts to address the perceived risks associated with counterfeit and...more
8/12/2025
/ Consumer Protection Laws ,
Enforcement Actions ,
False Advertising ,
Federal Trade Commission (FTC) ,
Food and Drug Administration (FDA) ,
Pharmaceutical Industry ,
Popular ,
Prescription Drugs ,
Regulatory Oversight ,
State Attorneys General ,
Telehealth
Blank Rome presents a new summer webinar series where our interdisciplinary team will unpack the most pressing legal, regulatory, and policy developments from the Trump Administration’s first 180 days.
Each session offers...more
7/3/2025
/ Acquisitions ,
Artificial Intelligence ,
Cartels ,
CIPA ,
Climate Change ,
Contract Termination ,
Cybersecurity ,
Data Privacy ,
Department of Health and Human Services (HHS) ,
Department of Justice (DOJ) ,
Deregulation ,
Digital Health ,
Disparate Impact ,
Diversity ,
Economic Sanctions ,
Employer Liability Issues ,
Enforcement Actions ,
Enforcement Priorities ,
Environmental Litigation ,
Environmental Policies ,
Equal Employment Opportunity Commission (EEOC) ,
Executive Orders ,
Export Controls ,
Federal Acquisition Regulations (FAR) ,
Federal Contractors ,
Food and Drug Administration (FDA) ,
Foreign Corrupt Practices Act (FCPA) ,
Health Care Providers ,
Health Insurance Portability and Accountability Act (HIPAA) ,
Life Sciences ,
Maritime Transport ,
Mergers ,
New Rules ,
NLRB ,
PFAS ,
Popular ,
Section 301 ,
Self-Disclosure Requirements ,
Sensitive Personal Information ,
Shipping ,
Superfund ,
Tariffs ,
Trade Wars ,
Trump Administration ,
Video Privacy Protection Act ,
Webinars ,
White Collar Crimes ,
Wiretapping